-
11β-HSD1 Inhibition and Liver Fibrosis
2026-09-05
A 2025 mouse study identifies 11β-HSD1 inhibition as an anti-fibrotic strategy that links reduced hepatic cortisol, Notch pathway suppression, and stronger natural killer cell responses. Its combination of fibrosis measurements, transcriptomics, and mass cytometry provides a mechanistic framework for studying endocrine–immune regulation of chronic liver injury.
-
AI-10-49 CBFβ-SMMHC Inhibitor Guide
2026-09-04
This scenario-driven guide shows how AI-10-49, a selective leukemia oncoprotein CBFβ-SMMHC inhibitor, can improve mechanistic interpretation of viability, proliferation, ChIP, and leukemia-model experiments. It provides practical guidance for using SKU A8694 with appropriate controls, solvent handling, and evidence-based readouts in acute myeloid leukemia research.
-
Demethyleneberberine in Huntington’s Disease
2026-09-04
The reference paper proposes Demethyleneberberine (DMB), a berberine metabolite, as a multi-pathway candidate for Huntington’s disease by linking redox control, mitochondrial protection, neuroinflammation, and neuronal survival. Its main value is hypothesis generation: it defines a mechanistic framework for testing DMB in Huntington’s disease models, while leaving dose, brain exposure, and disease-modifying efficacy to future experimental studies.
-
Puromycin dihydrochloride: Selection to Translation
2026-09-03
Use Puromycin dihydrochloride as a precisely calibrated selection reagent, translation probe, and cell-state perturbation tool rather than as a one-size-fits-all antibiotic. This workflow connects pac-gene engineering with glioma pathway studies, while emphasizing kill-curve design, exposure control, and interpretation limits.
-
MPP7, EMT, and Polarity in Ovarian Cancer
2026-09-03
The reference study identifies MPP7 as an overexpressed epithelial ovarian cancer factor associated with poor prognosis and links its activity to proliferation, migration, invasion, and altered cell polarity. By combining public datasets, tissue immunohistochemistry, functional interference, polarity imaging, transcriptome analysis, and Western blotting, the authors propose that MPP7 promotes EMT through Wnt/β-catenin signaling.
-
Cyanine 5-dCTP and the Next Wave of DNA Synthesis
2026-09-02
Cyanine 5-dCTP is more than a fluorescent label: it is a way to connect DNA synthesis performance with direct, sequence-linked measurement. This thought-leadership analysis examines how Cy5-dCTP can support fluorescent DNA labeling, enzymatic oligonucleotide synthesis, and translational assay development while distinguishing product attributes from findings demonstrated in DNA framework research.
-
Bradford Protein Assay Kit: Practical Protocol
2026-09-02
The Bradford Protein Assay Kit (SKU K4103) provides a rapid biochemical protein assay for measuring protein concentration from small-volume solution samples. It is suited to enzyme assays, protein purification, and protein assay for molecular biology workflows, but samples containing detergents or strong chaotropic agents require compatibility testing, dilution, or buffer exchange.
-
Cationic Lipid-Enriched LNPs for mRNA Vaccines
2026-09-01
This 2025 study systematically examines whether adding DOTAP or DODAP to ALC-0315-based lipid nanoparticles can improve intramuscular mRNA localization and vaccine responses. DOTAP produced composition-dependent gains in local expression and reduced hepatic expression at selected levels, but the immunogenicity advantage was modest and not sustained after boosting.
-
VX-765 Workflows for Caspase-1 Research
2026-08-31
VX-765 enables selective interrogation of caspase-1-driven cytokine release, pyroptosis, and barrier inflammation without broadly suppressing unrelated cytokines. This practical guide translates the blood-brain barrier findings of Israelov et al. into cell-based, biochemical, and translational workflows.
-
Phytol C5616: Reliable Cell Assay Workflows
2026-08-31
Learn how Phytol (SKU C5616) can be integrated into RXR-focused cell viability, proliferation, and cytotoxicity studies without confusing solvent effects or metabolic changes with cell death. This scenario-based guide covers formulation, concentration planning, interpretation, and lot-selection practices that support reproducible laboratory decisions.
-
Primidone: From Ion Channels to Translational Strategy
2026-08-30
Primidone, also known as Mysoline, is more than an established antiepileptic and anti-essential tremor drug. Its reported activity across TRPM3, RIPK1, and hPON1 creates a practical framework for translational researchers studying neurodevelopmental disorders, amyotrophic lateral sclerosis, and adenomyosis while carefully separating target engagement from disease-level efficacy.
-
Leupeptin Hemisulfate Salt Workflow Guide
2026-08-29
Leupeptin, Microbial provides reversible, competitive control of serine and cysteine proteases across biochemical, cell-based, antiviral, and autophagy workflows. This guide shows how to use it as a protease-control reagent while adapting the TET2 metabolite-binding workflow without confusing sample protection with direct epigenetic regulation.
-
BRD4770: From H3K9 Marks to Cancer Assays
2026-08-29
BRD4770 is a G9a histone methyltransferase inhibitor for connecting H3K9 methylation with senescence and cancer-cell phenotypes. This article shows how to interpret BRD4770 experiments across PANC-1 assays and pathway-focused breast cancer studies without overstating model-to-model evidence.
-
N-MYC/eIF4G1 Survival Axis in inv(16) AML
2026-08-28
Peramangalam et al. identify an N-MYC-driven survival program in inv(16) acute myeloid leukemia, linking a previously unrecognized MYCN enhancer to the translation factor eIF4G1. Their combination of transcriptomic, chromatin, genetic, cellular, primary-sample, and xenograft analyses provides a mechanistic framework for studying how CBFβ-SMMHC deregulates leukemia maintenance.
-
Phytol Assay Design: From RXR to Phase Behavior
2026-08-28
Phytol assay design requires more than selecting an RXR endpoint: solvent, isomer composition, concentration state, and biological context can reshape interpretation. This article connects Phytol receptor pharmacology with a polymer self-assembly study to develop a practical, evidence-aware workflow for advanced experiments.